Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Differences in evidentiary requirements for oncology drug assessments across health technology assessment bodies in Germany, Spain, and France, the European Medicines Agency, and the EU Health Technology assessment regulation.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: June 17, 2026
A review of methodological aspects of economic evaluations used in NICE assessments for treatments in metastatic breast cancer.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: July 20, 2025
Strengthening the EU Health Technology Assessment Regulation: Integrating National Immunization Technical Advisory Groups for Comprehensive Vaccine Assessments.
Journal: Journal of market access & health policy
Published: January 15, 2025
Market Access Challenges and Solutions in Cell and Gene Therapy in The Netherlands.
Journal: Journal of market access & health policy
Published: May 23, 2024
A Dutch cost-effectiveness analysis of fremanezumab versus best supportive care in patients with chronic migraine and inadequate response to prior preventive therapy.
Journal: BMC neurology
Published: October 20, 2023
Trends in NICE technology appraisals of non-small cell lung cancer drugs over the last decade.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: October 12, 2023
Differences in evidentiary requirements for oncology drug effectiveness assessments among six European health technology assessment bodies - can alignment be improved?
Journal: Expert review of pharmacoeconomics & outcomes research
Published: September 25, 2023
Differences in Evidentiary Requirements Between European Medicines Agency and European Health Technology Assessment of Oncology Drugs-Can Alignment Be Enhanced?
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: December 07, 2021
Cardiovascular Risk Management and Hepatitis C: Combining Drugs.
Journal: Clinical pharmacokinetics
Published: September 28, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026